<DOC>
	<DOC>NCT00748384</DOC>
	<brief_summary>The study purpose is to demonstrate that the target population can receive a packed FORESEE HOME unpack it, install and operate it to an extent that the FORESEE HOME can monitor them for changes in the visual field with good specificity. And evaluate the device usage on a small scale, at the subjects' homes before a commercial use.</brief_summary>
	<brief_title>Usability of the Foresee Home in Intermediate Age Related Macular Degeneration (AMD) Patients</brief_title>
	<detailed_description>Numerical output of the FORESEE HOME, output of the usability parameters provided by the FORESEE HOME device, counts of the number of subjects who successfully set up the device and conduct testing sessions.</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Capable and willing to sign a consent form and participate in the study Subjects diagnosed as intermediate AMD in at least one eye (in case a patient will convert during the study period he will be excluded) Age more than 50 years VA with habitual correction better than 20/60 in the study eye Ability to speak, read and understand instructions in English or Hebrew Familiar with computer usage Evidence of macular disease other than AMD or glaucoma in the study eye Presence of any significant media opacity that precludes a clear view of the macular area as identified in the study eye by biomicroscopy, CFP. Any nonmacular related ocular surgery performed within 3 months prior to study entry in the target eye Never been tested on the PHP device Participation in another study with the exclusion of AREDS study Patients diagnosed with geographic atrophy (GA)</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>HMP, CNV, AMD, PHP, HPHP, foresee</keyword>
</DOC>